# Eric B. Haura

Source: https://onco.cc/people/eric-haura/  
OnCo record `eric-haura` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Eric Haura is a lung cancer physician-scientist who maps drug-target signalling with proteomics.

## Summary

Eric B. Haura is Associate Center Director for Clinical Science and Director of the Lung Cancer Center of Excellence at Moffitt Cancer Center. He is a lung cancer physician-scientist known for mapping drug-target signalling with proteomics, using phosphoproteomics and protein-interaction mapping to understand why kinase inhibitors work and then fail. His selected paper reports proteomic and phosphoproteomic analyses of EGFR-mutant lung cancer. He now directs Moffitt's lung cancer centre and continues to study signalling networks in non-small-cell lung cancer.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Associate Center Director for Clinical Science; Director, Lung Cancer Center of Excellence
- Specialisms: Lung cancer; Proteomics; Signalling networks

## Sources

- Moffitt profile: https://www.moffitt.org/providers/eric-haura/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Haura%20EB%5BAuthor%5D

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Proteomics & phosphoproteomics](https://onco.cc/technologies/proteomics/)
- institutions: [Moffitt Cancer Center](https://onco.cc/institutions/moffitt/)
- journals: [Molecular Cancer Therapeutics](https://onco.cc/journals/molecular-cancer-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/eric-haura.json